Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Expert Analyses of the following article:

PERSONAL DOSE

Source: online.wsj.com
August 20, 2007
Major Step for Personalized Medicine: Warfarin Sensitivity DNA Test Required By FDA
Author: Kuldeepak Sharma, PhD, President/Pharmaceutical Consultant, Dr. Kuldeepak Sharma
The FDA has announced changes in the Warfarin label, recommending that a lower initial Warfarin dose should be considered for patients with certain genetic variations. Warfarin (Coumadin) is a commonly prescribed blood thinner with an exceptionally narrow safe-dosage range that varies dramatically from patient to patient. I think this label modification is one step closer to personalized medicine....
August 17, 2007
Coumadin Senstivity Testing Controversial
Author: Michael Grossbard, MD, Professor of Clinical Medicine, Columbia University College of Physicians and Surgeons
Coumadin is a frequently used and efficacious anticoagulant but patients must be monitored closely in order to avoid bleeding complications.  Genetic variations in coumadin metabolism contribute significantly to variations in bleeding risk and sensitivity to the anticoagulant effects of the drug.  A new FDA approved test allows the genetic differences to be measured.
August 17, 2007
Major Implications for Patients, Doctors, Insurers,Laboratories & Malpractice Attorneys
Author: GLG Expert Contributor
The FDA appears to be suggesting that all patients being started on warfarin be tested to access their rate of drug metabolism by genetic profiling.

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-11-21T13:45:47.600